Single-cell transcriptomics reveals that tumor-infiltrating natural killer cells are activated by localized ablative immunotherapy and share anti-tumor signatures induced by immune checkpoint inhibitors
K. Liu, N. Sadeghipour, A. R. Hoover, T. I. Valerio, C. Furrer, J. P. Adams, A. R. Naqash, M. Zhao, J. F. Papin, W. R. Chen
This study shows that localized ablative immunotherapy activates NK cells and shares anti-tumor gene signatures with immune checkpoint inhibitors, correlating with improved patient survival.
bioRxiv · May 2, 2023 · PreprintImmunology